Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Aug;98(35):e17053.
doi: 10.1097/MD.0000000000017053.

Adjuvant treatment with Xiaoqinglong formula for bronchial asthma: Protocol of systematic review and meta-analysis

Long Wang  1 , Xiuli Zheng  1 , Yi Hui  2 , Baojia Wang  1 , Yu Yang  1 , Xianrong Feng  3 , Tianyao Zhang  1 , Li Ma  1 , Xiaobo Zhang  1
Affiliations

Adjuvant treatment with Xiaoqinglong formula for bronchial asthma: Protocol of systematic review and meta-analysis

Long Wang et al. Medicine (Baltimore). 2019 Aug.

Abstract

Background: Bronchial asthma is one of the most common chronic diseases in the world and has become a serious public health problem. Combination therapy has become the first choice for clinical treatment of bronchial asthma. In addition to the combined use of routine medication, traditional Chinese medicine as an adjuvant therapy is also considered. Xiaoqinglong Decoction (XQLD) is an effective prescription of traditional Chinese medicine in treating asthma, and there are more and more clinical reports about its combination with western medicine in treating asthma. Therefore, we designed this study protocol to evaluate the adjuvant role of XQLD in the treatment of bronchial asthma.

Method: The following electronic databases will be systematically searched from inception to April 2019: PubMed, EMBASE database, Cochrane Library, China National Knowledge Infrastructure (CNKI), Wan Fang, Chinese Scientific Journals Database (VIP), and China Biology Medicine disc, (CBM). And the following primary outcomes will be tested, including effective rate (ER), pulmonary function (FEV1, PEF, FEV1/FVC), adverse reactions (AR). RevMan5 software will be used for literature quality evaluation and stata14.0 software will be used for data synthesis and analysis.

Result: To evaluate the efficacy and safety of Xiaoqinglong decoction in combination therapy by observing the outcomes of efficacy, adverse reactions and pulmonary function.

Conclusion: This study protocol will be used to evaluate the efficacy and safety of XQLD in combination with conventional drugs in the treatment of bronchial asthma, as well as the adjuvant role of XQLD in combination.

Prospero registration number: CRD42019133549.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Preferred reporting items for systematic reviews and meta-analyses flow chart of study selection process.
See this image and copyright information in PMC

References

    1. Kumar RM, Pajanivel R, Koteeswaran G, et al. Correlation of total serum immunoglobulin E level, sputum, and peripheral eosinophil count in assessing the clinical severity in bronchial asthma. Lung India 2017;34:256–61. - PMC - PubMed
    1. Mogensen I, Alving K, Dahlen SE, et al. Fixed airflow obstruction relates to eosinophil activation in asthmatics. Clin Exp Allergy 2019;49:155–62. - PubMed
    1. Jozsa T, Papp A, Gonczi F, et al. Studying the health behavior of asthmatic children regarding the dimensions of media and internet usage and self-esteem. Orv Hetil 2018;159:1971–80. - PubMed
    1. He WT, Huang HQ. research progress of bronchial asthma in traditional Chinese Medicine [in Chinese]. Helongjiang J Tradit Chin Med 2013;42:57–9.
    1. Song G, Zhang Y, Zhao K, et al. Regulatory effect of xiaoqinglong decoction on thymic stromal lymphopoietin (TSLP) inflammation promoter in mice with cold asthma. Iran J Allergy Asthma Immunol 2018;17:39–46. - PubMed

MeSH terms

Substances